HIGHLIGHTS
- who: V. Wee Yong and Mengzhou Xue from the Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China have published the research: Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice, in the Journal: (JOURNAL)
- what: The authors investigated the therapeutic benefits of an oral S1PR1/5 modulator Ozanimod in a mouse model of ICH.
- how: The flow chart of this experiment is showed in Figure 1A. This study was conducted in accordance with the Animal Care Committee of Zhengzhou University.
- future: The current study indicates that ozanimod . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.